Screener
Abbott ABT Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:EquityMethodInvestments.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
Abbott holds certain investments as of June 30, 2026, including investments accounted for under the equity method with a carrying value of $161 million and other equity investments with a carrying value of $238 million that do not have a readily determinable fair value.
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's equity method investments?
- Abbott (ABT) reported equity method investments of $161M in Q2 2026.
- How has Abbott's equity method investments changed year-over-year?
- Abbott's equity method investments increased by 1.9% year-over-year, from $158M to $161M.
- What is the long-term trend for Abbott's equity method investments?
- Over 5 years (2020 to 2025), Abbott's equity method investments has grown at a -30.7% compound annual growth rate (CAGR), from $821M to $131M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Abbott's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude